hiPSC Intestinal Organoids for Pharmacokinetics

2026-08-20

Gastrin I (human) in Organoid Assay Workflows

2026-08-20

Gastrin I (human) provides a defined CCK2 receptor stimulus for dissecting acid-related signaling, parietal-cell responses, and model-dependent gastrointestinal physiology. This guide combines practical peptide handling with a cautious extension of human pluripotent stem cell-derived intestinal organoid methods into comparative assay design.

EdU Imaging Kits (488) for S-Phase Analysis

2026-08-19

EdU Imaging Kits (488) provide a morphology-preserving route to quantify DNA synthesis in imaging and flow cytometry workflows. This practical guide applies the assay to NSCLC cell-cycle studies, with protocol starting points, controls, comparative advantages over BrdU, and troubleshooting strategies.

Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding

2026-08-19

Oliveira and colleagues found that naturally occurring angiotensin fragments can enhance SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects observed for selected shorter peptides and the spike–AXL interaction. The study provides a structure–activity framework linking peptide truncation and Tyr4 modification to receptor-binding changes, while also showing why cellular and physiological validation is still required.

CP-673451: Selective PDGFRα/β Assay Guide

2026-08-18

CP-673451 gives cancer researchers a focused way to interrogate PDGFRα/β signaling across phosphorylation, viability, angiogenesis, and xenograft workflows. Its nanomolar cellular activity and biomarker-oriented use in glioma models make it especially useful for connecting pathway inhibition with ATRX-defined response patterns.

Cediranib (AZD2171) for VEGFR Assays

2026-08-18

Cediranib (AZD2171) is a potent angiogenesis inhibitor for separating VEGFR pathway signaling from changes in proliferation and cell death. This workflow combines phospho-Akt measurements, concentration–response testing, and paired viability endpoints to improve interpretation in cancer research.

Nebivolol hydrochloride Assay Guide

2026-08-17

A scenario-driven guide to using Nebivolol hydrochloride (SKU B1341) in cell viability, proliferation, and cytotoxicity workflows. It covers receptor-specific interpretation, DMSO compatibility, assay controls, mTOR-screening boundaries, and practical product-selection criteria.

Drug-Sensitized Yeast for mTOR Inhibitor Discovery

2026-08-17

Breen and colleagues developed a genetically drug-sensitized Saccharomyces cerevisiae platform that markedly improves detection of TOR/mTOR pathway inhibitors. The system distinguishes TOR1-dependent growth inhibition at substantially lower concentrations than wild-type yeast and provides a practical early-stage screen for geroscience and oncology programs.

Methylprednisolone Sodium Succinate Lab Workflows

2026-08-16

Build more informative inflammation, leukocyte, and tumor-cell assays with a water-compatible synthetic corticosteroid and concentration-aware controls. This guide turns Methylprednisolone Sodium Succinate into a reproducible workflow for cytokine profiling, ROS testing, chemotaxis, apoptosis, and translational injury-model research.

Nurr1 Neurogenesis in the Rat Claustrum

2026-08-15

Fang, Wang, and Naumann mapped the developmental emergence and birth timing of Nurr1-positive neurons across the rat claustrum and adjacent lateral cortex. Their combination of developmental Nurr1 expression profiling with EdU birth dating reveals sequential neurogenesis and regional gradients that refine interpretation of claustrum boundaries and ontogeny.

Ceapin-A7 for Reproducible ER Stress Assays

2026-08-14

This scenario-driven guide shows how Ceapin-A7 (SKU BA3709) can help researchers isolate ATF6α signaling when interpreting viability, proliferation, and cytotoxicity data. It covers controls, dosing, storage, assay compatibility, and limitations when connecting ATF6α inhibition with PERK–JAK1–STAT3 biology.

EIF4A3–circEIF2S2 in Colorectal Cancer

2026-08-14

The reference study identifies an EIF4A3–circEIF2S2–miR-646–UHMK1 regulatory axis that links circular RNA biogenesis to colorectal cancer growth, metastasis, and immune suppression. Its combined molecular, cellular, co-culture, and xenograft evidence positions circEIF2S2 as a mechanistically informed biomarker candidate, while also highlighting the need for further validation in clinically representative models.

Sodium Oxamate: A Causal Lactylation Workflow

2026-08-13

Sodium Oxamate is more than an LDH-A inhibitor: it can help researchers test whether lactate-linked chromatin changes are causally connected to tumor behavior. This guide translates TNBC lactylation findings into a rigorous, interpretable cancer metabolism research workflow.

Nurr1 Gradients in the Developing Rat Claustrum

2026-08-13

Fang, Wang, and Naumann mapped the emergence and birth timing of Nurr1-positive neurons across the rat claustrum and adjacent lateral cortex. By combining developmental Nurr1 expression profiling with EdU birth dating, the study resolved sequential neurogenesis and spatial gradients that refine how claustral subregions are defined.

EGTA: Turning Calcium Signals Into Causal Insight

2026-08-12

EGTA, also known as egtazic acid, is more than a calcium chelator: it is a strategic perturbation tool for distinguishing calcium-dependent signaling from downstream cellular injury. This thought-leadership guide connects cardiac vagal neuron electrophysiology with translational workflows in neuroprotection, apoptosis assays, and inflammation research while defining practical limits for interpretation.